References
- Fulton MM, Allen ER. Polypharmacy in the elderly: a literature review. J Am Acad Nurse Pract 2005; 17: 123- 132. DOI: 10.111/j.1041-2972.2005.0020.x.
- Jones BA. Decreasing polypharmacy in clients most at risk. AACN Clin Issues 1997; 8: 627-634. https://doi.org/10.1097/00044067-199711000-00014
- Ziere G, Dieleman JP, Hofman A, Pols HA, van der Cammen TJ, Stricker BH. Polypharmacy and falls in the middle age and elderly population. Br J Clin Pharmacol 2006; 61: 218-223. DOI: 10.1111/j.1365-2125.2005.02543.x.
- Willey CJ, Andrade SE, Cohen J, Fuller JC, Gurwitz JH. Polypharmacy with oral antidiabetic agents: an indicator of poor glycemic control. Am J Manag Care 2006; 12: 435-440.
- Lee JS, Lee JE, Jung KY, et al., Polypharmacy and inappropriate drug prescription in community-dwelling elderly. J Korean Acad Fam Med 2008; 29: 925-931.
- Kim S. An analysis of effects by delisting non-ethical gastro-intestinal drugs. In College of Public Health. Seoul National University: Seoul, 2008.
- Cho HJ, Kim CB. Prescription behaviours of office-based doctors to standardized common cold patients in Korea. Pharmacoepidemiol Drug Saf 2002; 11: 401-405. DOI: 10.1002/pds.718.
- Byeon JJ. Prescription of digestive system drugs to the patients with no digestive symptoms. J Korean Acad Fam Med 1997; 18: 78-84.
- Viktil KK, Blix HS, Moger TA, Reikvam A. Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. Br J Clin Pharmacol 2007; 63: 187-195. DOI: 10.1111/j.1365-2125.2006.02744.x.
- Chong SA, Ravichandran N, Poon LY, Soo KL, Verma S. Reducing polypharmacy through the introduction of a treatment algorithm: use of a treatment algorithm on the impact on polypharmacy. Ann Acad Med Singapore 2006; 35: 457-460.